7,12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo.
Initiation and promotion are major stages in the multistage carcinogenesis process. Formation of initiating carcinogen-DNA base adducts leads to heritable genetic changes, but the tumor-promoting events induced by complete carcinogens have not, as yet, been elucidated. Oxidant production and oxidative DNA damage induced by phorbol esters (i.e., 12-O-tetradecanoyl-phorbol-13-acetate) are associated with tumor promotion, while antioxidants and inhibitors of oxidative DNA damage suppress promotion and carcinogenesis. Our goal was to establish whether a carcinogen that requires oxidative metabolism for its activity can also induce oxidant production and DNA base oxidation. We found that topical treatment of SENCAR mice with 7,12-dimethylbenz[a]anthracene, which induces tumors in 40-50% of the mice, also causes hydrogen peroxide production and formation of oxidized bases (i.e., 8-hydroxyl-2'-deoxyguanosine and 5-hydroxymethyl-2'-deoxyuridine) in epidermal DNA. The levels of oxidized bases were of comparable magnitude to those mediated by the potent tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate. The oxidized bases persisted over several weeks in epidermal DNA. These oxidative events appear to be temporally associated with inflammatory responses that include edema and polymorphonuclear leukocyte infiltration, which remained elevated over longer periods of time and at higher levels than those induced by phorbol ester. Because these processes are usually associated with tumor promotion, our results support the conjecture that oxidative events may be involved in what is operationally referred to as the tumor promotion process by 7,12-dimethylbenz[a]anthracene.
Frenkel
K
K
Department of Environmental Medicine, New York University Medical Center, New York, NY 10016-6451, USA.
Wei
L
L
Wei
H
H
D000080242:8-Hydroxy-2'-Deoxyguanosine / Q000031:analogs & derivatives; D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002273:Carcinogens / Q000633:toxicity*; D004247:DNA / Q000187:drug effects*; D004249:DNA Damage; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives / Q000032:analysis; D006861:Hydrogen Peroxide / Q000378:metabolism; D051379:Mice; D018632:Mice, Inbred SENCAR; D009504:Neutrophils / Q000201:enzymology; D010084:Oxidation-Reduction; D009195:Peroxidase / Q000097:blood; D012867:Skin / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D013936:Thymidine / Q000031:analogs & derivatives / Q000032:analysis
D000975:Antioxidants; D002273:Carcinogens; C018080:5-hydroxymethyl-2'-deoxyuridine; D015127:9,10-Dimethyl-1,2-benzanthracene; D006147:Guanine; C078307:8-oxo-7,8-dihydrodeoxyguanine; D000080242:8-Hydroxy-2'-Deoxyguanosine; D004247:DNA; D006861:Hydrogen Peroxide; D009195:Peroxidase; D013755:Tetradecanoylphorbol Acetate; D013936:Thymidine